HM Payson & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$99.5M Buy
391,709
+36,039
+10% +$8.4M 1.32% 21
2026
Q1
$86.9M Buy
355,670
+2,366
+0.7% +$551K 1.25% 25
2025
Q4
$73.1M Sell
353,304
-1,328
-0.4% -$263K 1.03% 26
2025
Q3
$65.8M Buy
354,632
+964
+0.3% +$165K 0.95% 30
2025
Q2
$54M Sell
353,668
-6,527
-2% -$1M 0.86% 35
2025
Q1
$59.7M Sell
360,195
-10,422
-3% -$1.63M 1.05% 33
2024
Q4
$53.6M Sell
370,617
-13,456
-4% -$2.09M 0.91% 34
2024
Q3
$62.2M Sell
384,073
-15,501
-4% -$2.47M 1.07% 31
2024
Q2
$58.4M Sell
399,574
-325,243
-45% -$48.4M 1.06% 33
2024
Q1
$115M Sell
724,817
-34,577
-5% -$5.5M 2.13% 8
2023
Q4
$119M Sell
759,394
-20,994
-3% -$3.22M 2.47% 6
2023
Q3
$122M Sell
780,388
-39,290
-5% -$6.48M 2.85% 6
2023
Q2
$136M Buy
819,678
+1,051
+0.1% +$170K 3.05% 5
2023
Q1
$127M Buy
818,627
+8,264
+1% +$1.33M 3.04% 4
2022
Q4
$143M Buy
810,363
+26,825
+3% +$4.63M 3.57% 3
2022
Q3
$128M Buy
783,538
+24,188
+3% +$4.09M 3.51% 3
2022
Q2
$135M Buy
759,350
+23,586
+3% +$4.2M 3.46% 3
2022
Q1
$130M Buy
735,764
+15,926
+2% +$2.71M 2.97% 4
2021
Q4
$123M Sell
719,838
-34,223
-5% -$5.6M 2.68% 4
2021
Q3
$122M Buy
754,061
+2,147
+0.3% +$366K 2.96% 4
2021
Q2
$124M Buy
751,914
+39,407
+6% +$6.52M 3.02% 4
2021
Q1
$117M Buy
712,507
+12,664
+2% +$2.05M 3.12% 3
2020
Q4
$110M Buy
699,843
+11,262
+2% +$1.66M 3.04% 4
2020
Q3
$103M Buy
688,581
+37,119
+6% +$5.49M 3.16% 4
2020
Q2
$91.6M Buy
651,462
+12,226
+2% +$1.78M 3.07% 4
2020
Q1
$83.8M Buy
639,236
+513
+0.1% +$72.8K 3.29% 3
2019
Q4
$93.2M Buy
638,723
+32,856
+5% +$4.46M 2.99% 3
2019
Q3
$78.4M Buy
605,867
+13,378
+2% +$1.76M 2.76% 3
2019
Q2
$82.5M Buy
592,489
+36,240
+7% +$5.02M 2.96% 3
2019
Q1
$77.8M Buy
556,249
+550,830
+10,165% +$73.8M 2.97% 3
2018
Q4
$699K Sell
5,419
-530,863
-99% -$74.1M 2.05% 15
2018
Q3
$74.1M Sell
536,282
-79,328
-13% -$10.5M 3.32% 3
2018
Q2
$74.7M Buy
615,610
+11,491
+2% +$1.43M 3.19% 3
2018
Q1
$77.4M Buy
604,119
+19,171
+3% +$2.59M 3.19% 2
2017
Q4
$81.7M Buy
584,948
+12,822
+2% +$1.79M 3.29% 1
2017
Q3
$74.4M Buy
572,126
+696
+0.1% +$92.3K 3.2% 2
2017
Q2
$75.6M Sell
571,430
-4,071
-0.7% -$519K 3.41% 1
2017
Q1
$71.7M Buy
575,501
+6,678
+1% +$798K 3.27% 3
2016
Q4
$65.5M Sell
568,823
-223
-0% -$25.8K 3.12% 2
2016
Q3
$67.2M Sell
569,046
-19,675
-3% -$2.39M 3.28% 2
2016
Q2
$71.4M Sell
588,721
-17,446
-3% -$1.98M 3.57% 2
2016
Q1
$65.6M Buy
606,167
+5,040
+0.8% +$522K 3.41% 2
2015
Q4
$61.7M Buy
601,127
+27,805
+5% +$2.8M 3.17% 2
2015
Q3
$53.5M Sell
573,322
-5,867
-1% -$568K 2.9% 3
2015
Q2
$56.4M Sell
579,189
-8,256
-1% -$827K 2.81% 3
2015
Q1
$59.1M Sell
587,445
-25,406
-4% -$2.58M 2.95% 2
2014
Q4
$64.1M Buy
612,851
+2,566
+0.4% +$270K 3.17% 2
2014
Q3
$65M Sell
610,285
-5,542
-0.9% -$575K 3.33% 2
2014
Q2
$64.4M Sell
615,827
-3,294
-0.5% -$333K 3.31% 2
2014
Q1
$60.8M Sell
619,121
-9,993
-2% -$926K 3.22% 2
2013
Q4
$57.6M Buy
629,114
+5,396
+0.9% +$497K 3.09% 2
2013
Q3
$54.1M Sell
623,718
-6,522
-1% -$585K 3.14% 2
2013
Q2
$54.1M Buy
+630,240
New +$53.5M 3.25% 2

Other funds holding JNJ

HM Payson & Co's JNJ Position: Q2 2026 in Review

HM Payson & Co increased its Johnson & Johnson (JNJ) stake by 10% in Q2 2026, buying an estimated $8.4M and bringing the position to 391,709 shares worth $99.5M. The position accounts for 1.32% of the portfolio, ranked #21.

HM Payson & Co first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $143M in Q4 2022. 1,021 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • HM Payson & Co held 391,709 shares of Johnson & Johnson worth $99.5M as of Q2 2026.
  • HM Payson & Co bought 36,039 Johnson & Johnson shares in Q2 2026, an estimated $8.4M.
  • Johnson & Johnson made up 1.32% of HM Payson & Co's portfolio in Q2 2026, its #21 holding.
  • HM Payson & Co first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • HM Payson & Co's Johnson & Johnson position peaked at $143M in Q4 2022.
  • 1,021 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.